| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |